Potential Synergy of Fluoxetine and Antibacterial Agents Against Skin and Soft Tissue Pathogens and Drug-Resistant Organisms
2024

Fluoxetine and Antibiotics: A New Approach to Fight Infections

Sample size: 21 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ahmed Samar A., Jordan Rondelle L., Isseroff Roslyn Rivkah, Lenhard Justin R.

Primary Institution: California Northstate University College of Pharmacy

Hypothesis

Can fluoxetine achieve synergistic effects with antibacterial agents against skin and soft tissue pathogens?

Conclusion

Fluoxetine combined with polymyxin B shows potential for treating difficult Gram-negative infections.

Supporting Evidence

  • Fluoxetine showed MICs ranging from 64 to 128 mcg/mL for Gram-positive isolates.
  • Fluoxetine and polymyxin B achieved synergy in 12 out of 15 Gram-negative isolates.
  • Levofloxacin and fluoxetine were synergistic against one Gram-positive isolate.
  • The combination of fluoxetine and polymyxin B may enhance treatment for drug-resistant pathogens.

Takeaway

This study looks at how fluoxetine, a common antidepressant, can help antibiotics work better against tough bacteria that cause skin infections.

Methodology

The study used broth microdilution to determine MICs and checkerboard experiments to assess synergy between fluoxetine and various antibiotics.

Potential Biases

Potential bias in selecting bacterial strains and interpreting synergy results.

Limitations

The study's findings may not translate directly to clinical settings due to challenges in delivering fluoxetine effectively to infection sites.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/antibiotics13121165

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication